CDHA CAAR

April 28, 2016

CAAR – US Senate Special Committee on Aging Hearing Testimony – April 28, 2016

Filed under: Legislation Information Updates — Tags: , — admin @ 4:40 pm

“‘Valeant Pharmaceuticals’ Business Model: the Repercussions for Patients and the Health Care System,” a hearing held April 27, 2016 (witness statement available in .pdf format, video of the full hearing available at the site, running time 3 hours 1 minute). Note: Hearing begins at the 9:54 mark and ends at the 3:10:19 mark

www.aging.senate.gov/hearings/valeant-pharmaceuticals-business-model-the-repercussions-for-patients-and-the-health-care-system

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress